pharmacie et médicaments – Accès aux traitements contre le myélome multiple

This written question concerns the accessibility of treatments for multiple myeloma, a type of blood cancer. It highlights potential disparities in access to innovative therapies. The question seeks to understand the government's strategy to ensure equitable access to these vital treatments for all patients across France.